kok手机app官方网站是德甲多特蒙德官方合作伙伴,全球领先的合法购彩公司,kok手机app官方网站拥有官方颁发的许可证并受其监督运营,专业提供体育电竞、真人娱乐、彩票投注等的正规购彩网站,kok手机app官方网站为每一位用户提供最完善的服务和最快乐的时光!

<big id="ncxeq"><nobr id="ncxeq"><track id="ncxeq"></track></nobr></big>
  • <center id="ncxeq"><small id="ncxeq"><track id="ncxeq"></track></small></center>
    <object id="ncxeq"></object>
    <tr id="ncxeq"><sup id="ncxeq"><mark id="ncxeq"></mark></sup></tr>
  • <strike id="ncxeq"></strike>
    <big id="ncxeq"><nobr id="ncxeq"><track id="ncxeq"></track></nobr></big>
  • <strike id="ncxeq"></strike>
    <center id="ncxeq"><em id="ncxeq"><p id="ncxeq"></p></em></center>

    I. Development of therapeutic antibody against specific targets by combinatorial antibody libraries:
    Human combinatorial antibody libraries contain 1011 diversity. We apply this antibody libraries to therapeutic targets in major diseases such as cancer, diabetes and neuronal diseases. New functional antibodies may provide novel therapeutic strategies for diseases.



    II. Unbiased functional antibody screening by combinatorial antibody libraries:

    We have established an efficient method for identification of novel therapeutic targets by using combinatorial antibody libraries. In this method, we screen functional antibodies against specific disease models and identify the targets by proteomic analysis. By this approaches, we are aiming to discover novel therapeutic targets and propose new functional antibodies.

    kok手机app官方网站

    <big id="ncxeq"><nobr id="ncxeq"><track id="ncxeq"></track></nobr></big>
  • <center id="ncxeq"><small id="ncxeq"><track id="ncxeq"></track></small></center>
    <object id="ncxeq"></object>
    <tr id="ncxeq"><sup id="ncxeq"><mark id="ncxeq"></mark></sup></tr>
  • <strike id="ncxeq"></strike>
    <big id="ncxeq"><nobr id="ncxeq"><track id="ncxeq"></track></nobr></big>
  • <strike id="ncxeq"></strike>
    <center id="ncxeq"><em id="ncxeq"><p id="ncxeq"></p></em></center>